Position in LLY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$3,550,313
+$2,031,773 QoQ
Shares Held
2,960
+79.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#1,989
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Whitener Capital Management, Inc. holds $31,660,073 across 7 Drug Manufacturers - General names. LLY ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
41,935 | $10,552,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,121 | $6,633,950 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,420 | $5,836,470 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
2,960 | $3,550,313 | |
| 5 | AMGN |
Amgen Inc
|
5,665 | $2,051,409 | |
| 6 | PFE |
Pfizer Inc
|
82,959 | $1,997,652 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,214 | $1,037,756 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,550,313 | 2,960 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,518,540 | 1,651 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,566,883 | 1,458 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,104,061 | 1,447 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,149,027 | 1,474 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,223,172 | 1,481 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,404,268 | 1,819 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,650,506 | 1,863 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,444,081 | 1,595 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,095,367 | 1,408 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $697,172 | 1,196 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||